Corporate

Corporate Overview, Investor’s Portal – PPM, Financial Highlights, Flipbook: Seed Funding Deck, Regulatory & Compliance, Recent News & updates, Documents & Downloads, Contact Investor Relation 

PPM –  Seed Funding – Series A – Corporate – Centers

Equipment Leasing, AiLc HealthOS2 (App), Humanoid Team Member, Mobile Medical Units, Franchise Program, Medical Research

Corporate PPMs

Strategic Growth Engines Beyond Clinics
The Corporate PPM offerings provide investors with targeted opportunities in high-growth verticals that complement AiLc’s clinical network in different Corporate APVs. These include:

  • AiLc Equipment Leasing: Ownership and leasing of AI-integrated MRI units, hyperbaric chambers, and diagnostic technologies.

  • AiLc HealthOS² (App): Our proprietary digital platform for patient engagement, data integration, and remote monitoring.

  • AiLc Humanoid Team Members: AI-powered humanoid assistants to support patient navigation, clinical workflows, and customer service.

  • AiLc Mobile Medical Centers: Portable diagnostic and treatment units designed to extend AiLc’s reach into underserved markets.

  • AiLc Franchise Program: A groundbreaking opportunity for individual doctor’s offices and small medical centers to join the AiLc ecosystem. Early franchise partners gain access to AiLc’s brand, AI technologies, training, and patient pipeline — all with no initial franchise fee for the first wave of centers. This program lowers the barrier to entry while fostering rapid nationwide adoption of longevity medicine.
  • Medical Research Center: A dedicated program to host clinical research teams within AiLc Level 1 Medical Centers. These research units will rent space, conduct patient-based studies, and share profits with the host clinic, creating new revenue while positioning AiLc at the forefront of longevity-focused scientific innovation.

Third (3rd) Quarter, Corporate PPMs / Financial Summary 

These initiatives create diversified revenue streams and long-term shareholder value while aligning with our vision of making longevity medicine accessible, affordable, and scalable.